Singapore develops new compounds to kill multi drug-resistant TB - BSA bureau

8/4/2022 12:00:00 AM2 years 9 months ago

US' Neuro-Horizon Pharma licenses promising compounds from NTU Singapore to combat multidrug-resistant tuberculosis

US-based Neuro-Horizon Pharma licenses promising compounds from NTU Singapore to combat multi drug-resistant tuberculosis With multi drug-resistant tuberculosis (TB) causing outbreaks in both devel… [+1144 chars]

full article...